scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Maria Masucci | Q39683404 |
P2093 | author name string | E Klein | |
P2860 | cites work | The transformation of adult but not newborn human lymphocytes by Epstein Barr virus and phytohemagglutinin is inhibited by interferon: the early suppression by T cells of Epstein Barr infection is mediated by interferon | Q45805720 |
Memory of Epstein-Barr virus-specific cytotoxic T cells in normal seropostive adults as revealed by an in vitro restimulation method | Q45805845 | ||
Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines | Q45826585 | ||
A permanent human cytotoxic T-cell line with high killing capacity against a lymphoblastoid B-cell line shows preference for HLA A, B target antigens and lacks spontaneous cytotoxic activity | Q52225931 | ||
Establishment of cell lines from peripheral leucocytes in infectious mononucleosis. | Q52834027 | ||
The role of gene dosage and genetic transpositions in carcinogenesis | Q53569200 | ||
Effect of Immunization on the Spread of Transplanted Mouse Lymphoma Cells2 | Q54504989 | ||
Use of cryopreserved lymphocytes for the indirect leukocyte migration inhibition assay | Q61788196 | ||
Spontaneous cell-mediated cytotoxicity in humans. Distribution and characterization of the effector cell | Q67415874 | ||
Disappearance of the NK effect after explantation of lymphocytes and generation of similar nonspecific cytotoxicity correlated to the level of blastogenesis in activated cultures | Q70524148 | ||
Interferon production and activation of non-specific effector cells by stimulation with lymphoblastoid cell lines in vitro | Q72647232 | ||
Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis | Q35077262 | ||
Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes | Q36335723 | ||
Target selectivity of interferon-induced human killer lymphocytes related to their Fc receptor expression | Q36394762 | ||
HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus | Q36398950 | ||
Tumorigenicity of human hematopoietic cell lines in athymic nude mice | Q39140286 | ||
EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients | Q39366390 | ||
Lymphocyte transformation induced by autologous cells. III. Lymphoblast-induced lymphocyte to stimulation does not correlate with EB viral antigen expression or immunity | Q39366634 | ||
Lymphoblastoid Cell Lines are Polyclonal Activators of Human T Lymphocytes | Q39536179 | ||
Lymphocyte transformation induced by autologous cells. V. generation of immunologic memory and specificity during the autologous mixed lymphocyte reaction | Q39835040 | ||
Cultivation with K562 cells leads to blastogenesis and increased cytotoxicity with changed properties of the active cells when compared to fresh lymphocytes | Q39871271 | ||
Enhanced destruction of lymphoid cell lines by peripheral blood leukocytes taken from patients with acute infectious mononucleosis | Q39943433 | ||
Human lymphoblastoid cell lines derived from individuals without lymphoproliferative disease contain the same latent forms of epstein-barr virus dna as those found in tumor cells | Q40091396 | ||
An immunological basis for inhibition of transformation of human lymphocytes by EB virus | Q40093785 | ||
Variable Phenotypic Expression of an X-Linked Recessive Lymphoproliferative Syndrome | Q40101109 | ||
Epstein-Barr-Virus Immunity and Tissue Distribution in a Fatal Case of Infectious Mononucleosis | Q40119435 | ||
Induction of ebna precedes the first cellular S-phase after ebv-infection of human lymphocytes | Q40129192 | ||
Studies on cytotoxicity generated in human mixed lymphocyte cultures. I. Time course and target spectrum of several distinct concomitant cytotoxic activities | Q40140874 | ||
Cell-density-dependence for growth in agarose of two human lymphoma lines and its decrease after epstein-barr virus conversion | Q40198212 | ||
Characterization of thymus-derived lymphocyte subsets in acute Epstein-Barr virus-induced infectious mononucleosis | Q40204672 | ||
Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte cultures | Q40238404 | ||
Cells containing Epstein--Barr nuclear antigen (EBNA) in peripheral blood | Q40256472 | ||
Inhibition of the in vitro outgrowth of Epstein-Barr virus-infected lymphocytes by TG lymphocytes | Q40260453 | ||
Activation of Suppressor T Cells during Epstein-Barr-Virus-Induced Infectious Mononucleosis | Q40262031 | ||
EBV specific killer T cells and serologic responses after onset of infectious mononucleosis | Q40268762 | ||
Characterization of cytotoxic human lymphocyte subpopulations: The role of Fc-receptor-carrying cells | Q40657154 | ||
Human spontaneous killer cells selective for tumour-derived target cells | Q40669355 | ||
Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus | Q40850280 | ||
Activation of Lymphocytes from Epstein-Barr Virus-Seronegative Donors by Autologous Epstein-Barr Virus-Transformed Cells | Q43684586 | ||
Cell-surface immunoglobulin and insulin receptor expression in an EBV-negative lymphoma cell line and its EBV-converted sublines | Q44064280 | ||
T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis | Q44658488 | ||
Lymphocyte Reactivity in Infectious Mononucleosis | Q44815388 | ||
Epstein Barr virus selective T cells in infectious mononucleosis are not restricted to HLA-A and B antigens | Q45214821 | ||
Effect of different Epstein-Barr virus-determined antigens (EBNA, EA, and VCA) on the leukocyte migration of healthy donors and patients with infectious mononucleosis and certain immunodeficiencies | Q45799773 | ||
Generationin vitro of HLA-restricted EB virus-specific cytotoxic human T cells by autologous lymphoblastoid cell lines: The roles of previous EB virus infection and foetal calf serum | Q45800730 | ||
Studies on long-term T-cell-mediated immunity to epstein-barr virus in immunosuppressed renal allograft recipients | Q45800733 | ||
Cell-mediated immune reactions in three patients with malignant lymphoproliferative diseases in remission and abnormally high Epstein-Barr virus antibody titers | Q45801124 | ||
Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization | Q45801129 | ||
Long-term T-cell-mediated immunity to Epstein-Barr virus | Q45801134 | ||
Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinants | Q45801240 | ||
Cytotoxic cells induced in vitro by Epstein-Barr Virus antigens | Q45801579 | ||
Sequential appearance of Epstein-Barr virus nuclear and lymphocyte-detected membrane antigens in B cell transformation | Q45802007 | ||
Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein–Barr virus-induced B-cell lines | Q45802718 | ||
In vitro induction of cytotoxic T lymphocytes specific for Epstein-Barr virus-transformed cells: kinetics of autologous restimulation | Q45803877 | ||
The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell | Q45804001 | ||
Cellular immune defects to Epstein-Barr virus-determined antigens in young males | Q45805432 | ||
Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line | Q45805481 | ||
P433 | issue | 1 | |
P921 | main subject | Epstein–Barr virus | Q6900 |
P304 | page(s) | 63-73 | |
P577 | publication date | 1982-01-01 | |
P1433 | published in | Seminars in Immunopathology | Q15724576 |
P1476 | title | Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes | |
P478 | volume | 5 |
Search more.